Stephanie Irving, MHS

Marshfield Clinic Research Foundation
1000 North Oak Avenue
ML2
Marshfield, WI
USA 54449
Email: irving.stephanie@marshfieldclinic.org

Biographical Sketch:
2007-present -- Epidemiologist, Marshfield Clinic Research Foundation, Marshfield WI 2006-2007-- Project Coordinator, University of Florida College of Medicine, Gainesville FL Publications -- Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, Baggs J; the Vaccine Safety Datalink Investigation Group.Real-Time Surveillance to Assess Risk of Intussusception and Other Adverse Events After Pentavalent, Bovine-Derived Rotavirus Vaccine. Pediatr Infect Dis J. 2009 Nov 10. [Epub ahead of print]. Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine 2009 Nov 5;27(47):6546-9. Belongia E, Kieke B, Coleman L, Donahue J, Irving S, et al. Interim Within-Season Estimate of the Effectiveness of Trivalent Inactivated Influenza Vaccine Marshfield, Wisconsin, 2007--08 Influenza Season. Morbidity and Mortality Weekly Report 2008; 57(15): 393-98. Irving SA, Salmon DA, Curbow BA. Vaccine Risk Communication Interventions in the United States, 1996-2006: A Review. Current Pediatric Reviews 2007; 3(3): 238-47.